chr7-76058047-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The ENST00000315758.10(MDH2):c.398C>T(p.Pro133Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P133A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000315758.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MDH2 | NM_005918.4 | c.398C>T | p.Pro133Leu | missense_variant | 4/9 | ENST00000315758.10 | NP_005909.2 | |
MDH2 | NM_001282403.2 | c.398C>T | p.Pro133Leu | missense_variant | 4/8 | NP_001269332.1 | ||
MDH2 | NM_001282404.2 | c.77C>T | p.Pro26Leu | missense_variant | 3/8 | NP_001269333.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MDH2 | ENST00000315758.10 | c.398C>T | p.Pro133Leu | missense_variant | 4/9 | 1 | NM_005918.4 | ENSP00000327070 | P1 | |
MDH2 | ENST00000432020.2 | c.398C>T | p.Pro133Leu | missense_variant | 4/8 | 2 | ENSP00000408649 | |||
MDH2 | ENST00000443006.5 | c.77C>T | p.Pro26Leu | missense_variant | 3/8 | 2 | ENSP00000416929 | |||
MDH2 | ENST00000461665.5 | n.423C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250528Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135526
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461300Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 726976
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 51 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 18, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 18, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 27, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing in multiple families [PMID 27989324] - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 17, 2023 | Variant summary: MDH2 c.398C>T (p.Pro133Leu) results in a non-conservative amino acid change located in the Lactate/malate dehydrogenase, N-terminal domain (IPR001236) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 250528 control chromosomes (gnomAD). c.398C>T has been reported in the literature in individuals affected with MDH2 deficiency/MDH2 related disorders (examples: Ait-El-Mkadem_2017, Laemmle_2021, Priestley_2022). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. This variant (Yeast P128L) protein failed to rescue the growth defect of yeast MDH2 null strain, suggesting P133L significantly disrupts aerobic respiration (examples: Ait-El-Mkadem_2017). The following publications have been ascertained in the context of this evaluation (PMID: 27989324, 34712577, 36420423). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Infantile encephalopathy Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Service de Génétique Médicale, Centre Hospitalier Universitaire de Nice-Université Côte d'Azur | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Department of Metabolic Diseases, Wilhelmina Children's Hospital | - | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 133 of the MDH2 protein (p.Pro133Leu). This variant is present in population databases (rs375002796, gnomAD 0.01%). This missense change has been observed in individual(s) with MDH2-related conditions (PMID: 27989324, 34712577). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 265769). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MDH2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MDH2 function (PMID: 27989324). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 09, 2022 | Published functional studies demonstrate a damaging effect (p.P133L expressed in yeast with knockout failed to rescue knockout growth-deficiency, suggesting P133L significantly disrupts aerobic respiration) (Ait-El-Mkadem et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36420423, 27989324, 34827632, 34766628, 36079864, 35008954, 34712577) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at